SLC9A1 and neoplasm: Studies have confirmed that NHE1, HVCn1, and V-type proton pumps can promote the proliferation, migration, and drug resistance of tumor cells225–234, and silencing NHE1 or SLC4A7 significantly reduced tumor growth in a mouse xenograft model235.